Grace Therapeutics Inc. (GRCE)
NASDAQ: GRCE
· Real-Time Price · USD
3.02
0.00 (0.00%)
At close: Oct 03, 2025, 3:59 PM
3.01
-0.50%
After-hours: Oct 03, 2025, 05:50 PM EDT
Grace Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Cash & Equivalents | 20M | 22.13M | 11.05M | 15.15M | 19.39M | 23M | 18.55M | 26.99M | 21.63M | 27.88M | 26.24M | 34.93M | 38.38M | 30.34M | 33.01M | 36.93M | 40.98M | 50.94M | 26.55M | 11.55M | 12.12M |
Short-Term Investments | n/a | n/a | n/a | 15K | 15K | n/a | 6.57M | 15K | 15K | 15K | 5.01M | 14K | 16K | 13.32M | 13.31M | 13.86M | 16.75M | 9.79M | 1.37M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 192K |
Receivables | 20K | 126K | 301K | 415K | 398K | 722K | 959K | 837K | 837K | 802K | 778K | 859K | 964K | 548K | 238K | 813K | 448K | 530K | 619K | 625K | 495K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14K | n/a | n/a |
Other Current Assets | 500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 352K | 352K | 352K | 352K | 587K | 764K | 778K | 768K | 1.09M | 1.05M | 629K |
Total Current Assets | 20.52M | 22.71M | 11.94M | 16.06M | 20.43M | 24.01M | 26.88M | 28.89M | 23.61M | 29.29M | 33.43M | 37.51M | 41.25M | 45.28M | 49M | 54.55M | 60.39M | 62.37M | 30.2M | 13.71M | 13.96M |
Property-Plant & Equipment | n/a | 15K | 19K | 21K | 23K | 24K | 35K | 57K | 155K | 567K | 599K | 632K | 909K | 565K | 22K | 43K | 66K | 86K | 105K | 119K | 2.06M |
Goodwill & Intangibles | 49.27M | 49.27M | 49.27M | 49.27M | 49.27M | 49.27M | 49.27M | 49.27M | 49.27M | 49.27M | 82.77M | 82.77M | 82.77M | 82.77M | 65.21M | 65.21M | n/a | n/a | n/a | n/a | 3.92M |
Total Long-Term Assets | 49.28M | 49.28M | 49.28M | 49.29M | 49.29M | 49.29M | 49.3M | 49.32M | 49.42M | 49.83M | 83.37M | 83.41M | 83.68M | 83.34M | 65.23M | 65.25M | 66K | 86K | 105K | 119K | 6.18M |
Total Assets | 69.81M | 71.99M | 61.22M | 65.35M | 69.72M | 73.3M | 76.19M | 78.21M | 73.03M | 79.12M | 116.8M | 120.91M | 124.93M | 128.62M | 114.23M | 119.8M | 60.45M | 62.46M | 30.3M | 13.83M | 20.14M |
Account Payables | n/a | 601K | 665K | 1.68M | 1.55M | 1.01M | 913K | 685K | 607K | 1.24M | 3.36M | 3.73M | 3.06M | 1.68M | 2.84M | 4.43M | 2.28M | 115K | 2.14M | 3.67M | 5.9M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 24K | 46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 2.31M | n/a | 814K | n/a | n/a | n/a | -24K | -46K | n/a | n/a | n/a | n/a | n/a | n/a | 32K | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 2.31M | 1.93M | 1.97M | 2.67M | 2.6M | 1.68M | 1.77M | 1.4M | 1.97M | 3.41M | 3.43M | 3.81M | 3.71M | 3.26M | 2.9M | 4.48M | 2.35M | 1.58M | 2.25M | 3.75M | 5.98M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.63M | 1.14M | 3.78M | 2.6M | 2.96M | 4.36M | 3.33M | 3.46M | n/a | n/a | n/a | n/a | n/a | 10K | 268K | 1.12M | 4.65M | 5.22M | 2.34M | 1.17M | 3.07M |
Total Long-Term Liabilities | 3.94M | 3.45M | 7.11M | 6.54M | 7.75M | 9.87M | 9.73M | 10.07M | 7.06M | 7.76M | 16.65M | 16.94M | 16.82M | 17.09M | 268K | 1.12M | 4.65M | 5.22M | 2.34M | 1.21M | 3.13M |
Total Liabilities | 6.25M | 5.38M | 9.09M | 9.21M | 10.35M | 11.56M | 11.51M | 11.46M | 9.02M | 11.17M | 20.08M | 20.75M | 20.53M | 20.35M | 3.17M | 5.59M | 7M | 6.8M | 4.59M | 4.96M | 9.11M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | 24K | 46K | 80K | 485K | 503K | 520K | 819K | 295K | 22K | 43K | 66K | 86K | 105K | 119K | 135K |
Book Value | 63.55M | 66.61M | 52.14M | 56.13M | 59.36M | 61.74M | 64.68M | 66.75M | 64.01M | 67.95M | 96.72M | 100.16M | 104.4M | 108.27M | 111.06M | 114.2M | 53.46M | 55.66M | 25.71M | 8.87M | 11.04M |
Book Value Per Share | 3.99 | 4.86 | 4.53 | 4.88 | 5.43 | 6.72 | 8.63 | 8.84 | 8.61 | 9.14 | 13.01 | 13.49 | 14.13 | 16.01 | 15.05 | 20.90 | 12.31 | 16.34 | 12.31 | 4.48 | 5.84 |
Common Stock | 1K | 1K | 1K | 261.04M | 261.04M | 261.04M | 261.04M | 261.04M | 258.29M | 258.29M | 258.29M | 258.29M | 258.19M | 257.99M | 257.99M | 258M | 197.19M | 197.19M | 162.2M | 142.57M | 139.19M |
Retained Earnings | -224.05M | -220.69M | -221.32M | -217.17M | -213.74M | -211.12M | -207.95M | -205.56M | -202.29M | -198.27M | -169.18M | -165.29M | -160.36M | -155.84M | -151.93M | -148.16M | -149.14M | -146.02M | -140.37M | -137.15M | -131.01M |
Comprehensive Income | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M | -6.53M | -6.72M | -5.57M | -6.33M | -6.93M | -7.4M | -7.58M |
Shareholders Equity | 63.55M | 66.61M | 52.14M | 56.13M | 59.36M | 61.74M | 64.68M | 66.75M | 64.01M | 67.95M | 96.72M | 100.16M | 104.4M | 108.27M | 111.06M | 114.2M | 53.46M | 55.66M | 25.71M | 8.87M | 11.04M |
Total Investments | n/a | n/a | n/a | 15K | 15K | n/a | 6.57M | 15K | 15K | 15K | 5.01M | 14K | 16K | 13.32M | 13.31M | 13.86M | 16.75M | 9.79M | 1.37M | n/a | n/a |